-The Indian Express If the BJP finds itself on the back foot today, it isn't because of corruption scandals, but due to the splintering of its social coalition As the stage is set for the state assembly elections in Karnataka, former Prime Minister H.D. Deve Gowda recently made a surprising admission: corruption is not an issue in the upcoming elections, and the precipitous decline in political morality can only be arrested by...

-The Hindustan Times Amid raging controversy over regulation of electronic media in India, the Delhi High Court on Tuesday recommended to the government to establish a statutory body to regulate the broadcast media, saying state intervention was necessary. "Absence of state intervention on its own is no guarantee of a rich media environment. On the contrary: to promote a media environment characterized by pluralism and diversity, State intervention is necessary," a bench...

-The Hindu     Drug patents are designed to create profits that enable more research on diseases affecting millions. But in practice, they have often generated super profits for big pharma companies while erecting access barriers for the poor. The Novartis case spotlights much that is wrong with the system. The rejection of the Novartis petition challenging one of the most progressive tenets of the Indian Patents Act (1970), as amended in 2005 by...

-The Indian Express Chandigarh: Slamming the Punjab government for sponsoring "xenophobia", the Punjab and Haryana High Court on Wednesday set aside its "discriminatory" rules, wherein it had allowed additional weightage to rural students for government jobs. A Full Bench comprising Justices Hemant Gupta, Ajay Tewari and R N Raina held the rules framed by Punjab as "illegal, unconstitutional" and beyond its "legislative competence". "State sponsored xenophobia is constitutional anathema and the principle...

-The Hindu   Supreme Court rejects Novartis' plea for patent; green signal for cheaper generic drugs In a ruling that will help patients continue to buy several life-saving medicines as generic drugs, the Supreme Court on Monday held that the modification of a well known cancer-fighting drug is not a patentable new invention. The judgment allows suppliers to continue making generic copies of Swiss firm Novartis' Glivec or Gleevec, which has been shown to...